Lyumjev ® (insulin lispro – aabc) injection

100 units/mL, 200 units/mL

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

LYUMJEV™ (insulin lispro-aabc): Commercial Presentations

For Lyumjev, concentrations of 100 and 200 units/mL have been assessed for commercial availability.

Commercial Presentations

The commercial presentations for Lyumjev 100 units/mL are similar to those of IL-100, and the Lyumjev 200 units/mL Pen to mirror the IL-200 Pen (Table 1).1

Table 1. Commercial Presentations of Lyumjev - Dosage Forms and Strengths1,2


Lyumjev 100 Units/mL

Lyumjev 200 Units/mL

10-mL vial



3-mL KwikPen®



3-mL Junior KwikPen®a



3-mL Tempo Pen™ba



3-mL cartridgea



Abbreviation: Lyumjev = Lyumjev™ (insulin lispro-aabc)

a Not marketed in US, yet.

b Tempo Pen™ is marketed in United States only.

Enclosed Prescribing Information

HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly

LYUMJEV™ (insulin lispro-aabc) injection, for subcutaneous or intravenous use, Lilly


1. Data on file, Eli Lilly and Company and/or one of its subsidiaries.

2. Lyumjev™ (insulin lispro-aabc) [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.


IL-100 = Humalog® (insulin lispro injection) 100 units/mL

IL-200 = Humalog® (insulin lispro injection) 200 units/mL

Lyumjev = Lyumjev™ (insulin lispro-aabc)

Pen = KwikPen®

Date of Last Review: May 29, 2020

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 7pm EST

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical